Real-time enrollment status for this uncontrolled hypertension clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:46 PM UTC
| NCT Number | NCT07142356 |
| Recruiting Status | Recruiting |
| Condition | Uncontrolled Hypertension |
| Phase | PHASE2 |
| Target Enrollment | 280 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Retension Pharmaceuticals. Inc. |
| Last Updated on CT.gov | June 29, 2026 (Jun 29, 2026) |
As of August 27, 2026: Clinical trial NCT07142356 is currently recruiting participants. This phase2 study for uncontrolled hypertension is actively seeking new participants at 22 locations across the United States. The study is sponsored by Retension Pharmaceuticals. Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07142356 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07142356 was last updated Jun 29, 2026 (June 29, 2026). HelloStudys verifies this status automatically.